PATENT CLAIM ANALYSIS

Application Number: 16031665
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "497000"]

Abstract:
A sterile pharmaceutical dosage form which comprises an ester capped lactide polymer, glycolide polymer or a lactide-glycolide copolymer hypercompressed with an active pharmaceutical ingredient wherein said sterile pharmaceutical dosage form has been sterilized with an electron beam and a method of preparing said sterile pharmaceutical dosage form.

Claim (Index 5):
A sterile pharmaceutical dosage form as defined in  claim 4  where the microcapsule has been compressed by the application of 100 Kpsi to 300 Kpsi.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.44118
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16032025', '12386853', '15981104', '13690647', '13408472']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7482564378590675
- 35 USC 102 Novelty (BERT): 0.5260367032193773
- Combined Prediction Score: 0.7260344643950984
- Mean Citation Score: 230.373748
- Max Citation Score: 334.43085
- Similarity Product: 264.9200824600518

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test